Lannett Begins Marketing Chlorpromazine Hydrochloride Tablets
- Monday, February 8, 2021, 7:10
- Business
- Add a comment
PHILADELPHIA, Feb. 8, 2021 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced that it has begun marketing Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 25 mg, 50 mg, 100 mg and 200 mg. The company recently received approval from the U.S. Food and Drug Administration…
About the Author
adminasapcorp has written 39592 stories on this site.